Literature DB >> 19324876

TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.

Siew Wee Chan1, Chun Jye Lim, Li Shen Loo, Yaan Fun Chong, Caixia Huang, Wanjin Hong.   

Abstract

The transcriptional coactivators YAP and TAZ are downstream targets inhibited by the Hippo tumor suppressor pathway. The expression level of TAZ is recently shown to be elevated in invasive breast cancer cells and some primary breast cancers. TAZ is important for breast cancer cell migration, invasion, and tumorigenesis, but the underlying mechanism is not defined. In this study, we show that TAZ interacts with TEAD transcriptional factors. Knockdown of TEADs suppresses TAZ-mediated oncogenic transformation of MCF10A cells. Uncoupling TAZ from Hippo regulation by S89A mutation enhances its transforming ability. Several residues located in the N-terminal region of TAZ are identified to be important for interaction with TEADs, and these same residues are equally important for TAZ to transform MCF10A cells. Mechanistically, TAZ mutants defective in interaction with TEADs fail to accumulate in the nucleus. Live cell imaging of enhanced green fluorescent protein-TAZ and its mutant defective in TEAD interaction suggests that TEAD interaction mediates nuclear retention. These results reveal a novel mechanism for TEADs to regulate nuclear retention and thus the transforming ability of TAZ.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324876      PMCID: PMC2682883          DOI: 10.1074/jbc.M901568200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.

Authors:  B Singh; S K Gogineni; P G Sacks; A R Shaha; J P Shah; A Stoffel; P H Rao
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

2.  TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.

Authors:  A Vassilev; K J Kaneko; H Shu; Y Zhao; M L DePamphilis
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

3.  A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.

Authors:  Masao Murakami; Masayo Nakagawa; Eric N Olson; Osamu Nakagawa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

Review 4.  TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation.

Authors:  Jeong-Ho Hong; Michael B Yaffe
Journal:  Cell Cycle       Date:  2006-01-16       Impact factor: 4.534

5.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Authors:  Zakir Hossain; Safiah Mohamed Ali; Hui Ling Ko; Jianliang Xu; Chee Peng Ng; Ke Guo; Zeng Qi; Sathivel Ponniah; Wanjin Hong; Walter Hunziker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

6.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

7.  TAZ, a transcriptional modulator of mesenchymal stem cell differentiation.

Authors:  Jeong-Ho Hong; Eun Sook Hwang; Michael T McManus; Adam Amsterdam; Yu Tian; Ralitsa Kalmukova; Elisabetta Mueller; Thomas Benjamin; Bruce M Spiegelman; Phillip A Sharp; Nancy Hopkins; Michael B Yaffe
Journal:  Science       Date:  2005-08-12       Impact factor: 47.728

8.  TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.

Authors:  F Kanai; P A Marignani; D Sarbassova; R Yagi; R A Hall; M Donowitz; A Hisaminato; T Fujiwara; Y Ito; L C Cantley; M B Yaffe
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

9.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

10.  Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ.

Authors:  Cai Bin Cui; Lyndon F Cooper; Xiangli Yang; Gerard Karsenty; Ikramuddin Aukhil
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more
  116 in total

1.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

2.  The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.

Authors:  Chen-Ying Liu; Zheng-Yu Zha; Xin Zhou; Heng Zhang; Wei Huang; Di Zhao; Tingting Li; Siew Wee Chan; Chun Jye Lim; Wanjin Hong; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

3.  Structural and functional analysis of the YAP-binding domain of human TEAD2.

Authors:  Wei Tian; Jianzhong Yu; Diana R Tomchick; Duojia Pan; Xuelian Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 4.  Hippo signaling: growth control and beyond.

Authors:  Georg Halder; Randy L Johnson
Journal:  Development       Date:  2011-01       Impact factor: 6.868

Review 5.  Concise Review: Stem Cell Microenvironment on a Chip: Current Technologies for Tissue Engineering and Stem Cell Biology.

Authors:  DoYeun Park; Jaeho Lim; Joong Yull Park; Sang-Hoon Lee
Journal:  Stem Cells Transl Med       Date:  2015-10-08       Impact factor: 6.940

6.  YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells.

Authors:  Dan Cheng; Lan Jin; Yunhe Chen; Xueyan Xi; Yang Guo
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

7.  Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.

Authors:  Gilson S Baia; Otavia L Caballero; Brent A Orr; Anita Lal; Janelle S Y Ho; Cynthia Cowdrey; Tarik Tihan; Christian Mawrin; Gregory J Riggins
Journal:  Mol Cancer Res       Date:  2012-05-22       Impact factor: 5.852

8.  A TEAD1/p65 complex regulates the eutherian-conserved MnSOD intronic enhancer, eRNA transcription and the innate immune response.

Authors:  Ann L Chokas; Justin S Bickford; Sarah J Barilovits; Richard J Rogers; Xiaolei Qiu; Kimberly J Newsom; Dawn E Beachy; Harry S Nick
Journal:  Biochim Biophys Acta       Date:  2014-06-19

9.  VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.

Authors:  Wenjing Zhang; Yijun Gao; Peixue Li; Zhubing Shi; Tong Guo; Fei Li; Xiangkun Han; Yan Feng; Chao Zheng; Zuoyun Wang; Fuming Li; Haiquan Chen; Zhaocai Zhou; Lei Zhang; Hongbin Ji
Journal:  Cell Res       Date:  2014-01-24       Impact factor: 25.617

10.  Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.

Authors:  Zeyu Yang; Kentaro Nakagawa; Aradhan Sarkar; Junichi Maruyama; Hiroaki Iwasa; Yijun Bao; Mari Ishigami-Yuasa; Shigeru Ito; Hiroyuki Kagechika; Shoji Hata; Hiroshi Nishina; Shinya Abe; Masanobu Kitagawa; Yutaka Hata
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.